Growth Metrics

Solid Biosciences (SLDB) Change in Account Payables (2017 - 2026)

Quarterly results put Change in Account Payables at $2.3 million for Q1 2026, up 403.47% from a year ago — trailing twelve months through Mar 2026 was $767000.0 (down 76.49% YoY), and the annual figure for FY2025 was -$1.1 million, down 149.57%.

Solid Biosciences has reported Change in Account Payables over the past 10 years, most recently at $2.3 million for Q1 2026.

  • Change in Account Payables reached $2.3 million in Q1 2026 per SLDB's latest filing, up from -$5.3 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $3.7 million in Q3 2025 and bottomed at -$5.9 million in Q4 2022.
  • Median Change in Account Payables over the past 5 years was $287000.0 (2022), compared with a mean of -$151588.2.
  • The largest annual shift saw Change in Account Payables crashed 1136.14% in 2022 before it soared 3766.2% in 2023.
  • Over 5 years, Change in Account Payables stood at -$5.9 million in 2022, then surged by 102.27% to $134000.0 in 2023, then skyrocketed by 508.21% to $815000.0 in 2024, then plummeted by 745.03% to -$5.3 million in 2025, then skyrocketed by 144.15% to $2.3 million in 2026.
  • Business Quant data shows Change in Account Payables for SLDB at $2.3 million in Q1 2026, -$5.3 million in Q4 2025, and $3.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -3.26 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 35.60 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Solid Biosciences 713.77 Mn 333.09 Mn - 2.32 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.32 Mn
Mar 31, 2026 2.32 Mn
Dec 31, 2025 -5.26 Mn
Dec 31, 2025 -5.26 Mn
Sep 30, 2025 3.70 Mn
Sep 30, 2025 3.70 Mn
Jun 30, 2025 6,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 461,000.00
Mar 31, 2025 461,000.00
Dec 31, 2024 815,000.00
Dec 31, 2024 815,000.00
Sep 30, 2024 918,000.00
Sep 30, 2024 918,000.00
Jun 30, 2024 1.07 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 -596,000.00
Mar 31, 2024 -596,000.00
Dec 31, 2023 134,000.00
Dec 31, 2023 134,000.00
Sep 30, 2023 -929,000.00
Sep 30, 2023 -929,000.00
Jun 30, 2023 -2.71 Mn
Jun 30, 2023 -2.71 Mn
Mar 31, 2023 2.75 Mn
Mar 31, 2023 2.75 Mn
Dec 31, 2022 -5.91 Mn
Dec 31, 2022 -5.91 Mn
Sep 30, 2022 287,000.00
Sep 30, 2022 287,000.00
Jun 30, 2022 302,000.00
Jun 30, 2022 302,000.00
Mar 31, 2022 71,000.00
Mar 31, 2022 71,000.00
Dec 31, 2021 570,000.00
Dec 31, 2021 570,000.00
Sep 30, 2021 957,000.00
Sep 30, 2021 957,000.00
Jun 30, 2021 -228,000.00
Jun 30, 2021 -228,000.00
Mar 31, 2021 -90,000.00
Mar 31, 2021 -90,000.00
Dec 31, 2020 -829,000.00
Dec 31, 2020 -829,000.00
Sep 30, 2020 1.29 Mn
Sep 30, 2020 1.29 Mn
Jun 30, 2020 417,000.00
Jun 30, 2020 417,000.00
Mar 31, 2020 -4.31 Mn
Mar 31, 2020 -4.31 Mn
Dec 31, 2019 3.77 Mn
Dec 31, 2019 3.77 Mn
Sep 30, 2019 -2.43 Mn
Sep 30, 2019 -2.43 Mn
Jun 30, 2019 771,000.00
Jun 30, 2019 771,000.00
Mar 31, 2019 1.67 Mn
Mar 31, 2019 1.67 Mn
Dec 31, 2018 -1.50 Mn
Dec 31, 2018 -1.50 Mn
Sep 30, 2018 950,000.00
Sep 30, 2018 950,000.00
Jun 30, 2018 -703,000.00
Jun 30, 2018 -703,000.00
Mar 31, 2018 -354,000.00
Mar 31, 2018 -354,000.00
Dec 31, 2017 -700,000.00
Dec 31, 2017 -700,000.00
Sep 30, 2017 3.54 Mn
Sep 30, 2017 3.54 Mn
Jun 30, 2017 -2.10 Mn
Jun 30, 2017 -2.10 Mn
Mar 31, 2017 832,000.00
Mar 31, 2017 832,000.00